Benchmark Initiates Coverage on Ceradyne (CRDN) with a Hold; Growing Solar Unlikely to Offset Deceleration in Body Armor

April 9, 2010 8:32 AM EDT Send to a Friend
Benchmark initiates coverage on Ceradyne (Nasdaq: CRDN) with a Hold rating and price target of $20.

Benchmark analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login